Enanta Pharmaceuticals (ENTA) Revenue (2012 - 2026)
Enanta Pharmaceuticals (ENTA) revenue from Mar 31, 2012 to Mar 31, 2026. The TTM Enanta Pharmaceuticals (ENTA) revenue is $54M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Enanta Pharmaceuticals (ENTA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -16.12% |
| 3 Years TTM | -3.87% |
| 5 Years TTM | -10.50% |
| 10 Years TTM | -4.69% |
| All Time TTM | +4.22% |
Annual Revenue change of Enanta Pharmaceuticals (ENTA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $17M | -73.73% |
| 2025 | $65M | -3.43% |
| 2024 | $68M | -14.60% |
| 2023 | $79M | -8.08% |
| 2022 | $86M | -11.24% |
| 2021 | $97M | -20.74% |
| 2020 | $122M | -40.32% |
| 2019 | $205M | +193.60% |
| 2018 | $70M | +83.39% |
| 2017 | $38M | +265.74% |
| 2016 | $10M | -78.49% |
| 2015 | $48M | -37.48% |
| 2014 | $78M | +8607.87% |
| 2013 | $890K | -96.81% |
| 2012 | $28M | +3664.86% |
| 2011 | $740K | N/A |
Comparison Enanta Pharmaceuticals (ENTA) five years revenue CAGR with competitors
Enanta Pharmaceuticals (ENTA) five years revenue CAGR is -10.49%.